Lyme And Co-infection Nosode Liquid
NDC Package 58048-0005-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Lyme And Co-infection Nosode (angelica archangelica, kali muriaticum, yucca filamentosa, cartilago suis, phytolacca decandra, hydrastis canadensis, rhus tox, causticum, magnesia phosphorica, manganum metallicum, oxalicum acidum, arnica montana, babesia microti, borrelia burgdorferi nosode, latrodectus mactans, citricum acidum, cytomegalovirus nosode, rickettsia nosode (rickettsia prowazekii), chlamydia trachomatis, ledum palustre) liquids is supports the immune system for host resistance to Lyme disease and co-infections. This formulation utilizes a liquid delivery system. Marketed by Bhp Holdings, Inc., this product is identified by NDC 58048-0005.

Identification & Billing

NDC Package Code
58048-0005-1
Package Description
60 mL in 1 BOTTLE, DROPPER
Product Code
58048-0005
11-Digit Billing Format
58048000501

Clinical Specifications

Proprietary Name
Lyme And Co-infection Nosode
Non-Proprietary Name
Angelica Archangelica, Kali Muriaticum, Yucca Filamentosa, Cartilago Suis, Phytolacca Decandra, Hydrastis Canadensis, Rhus Tox, Causticum, Magnesia Phosphorica, Manganum Metallicum, Oxalicum Acidum, Arnica Montana, Babesia Microti, Borrelia Burgdorferi Nosode, Latrodectus Mactans, Citricum Acidum, Cytomegalovirus Nosode, Rickettsia Nosode (rickettsia Prowazekii), Chlamydia Trachomatis, Ledum Palustre
Substance Name
Angelica Archangelica Root; Anhydrous Citric Acid; Arnica Montana; Babesia Microti; Borrelia Burgdorferi; Causticum; Chlamydia Trachomatis; Goldenseal; Human Herpesvirus 5; Latrodectus Mactans; Ledum Palustre Twig; Magnesium Phosphate, Dibasic Trihydrate; Manganese; Oxalic Acid; Phytolacca Americana Root; Potassium Chloride; Rickettsia Prowazekii; Sus Scrofa Cartilage; Toxicodendron Pubescens Leaf; Yucca Filamentosa
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Supports the immune system for host resistance to Lyme disease and co-infections. Supports the immune system for host resistance to Lyme disease and co-infections.

Regulatory & Marketing

Labeler Name
Bhp Holdings, Inc.
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
03-17-2020
End Marketing Date
09-19-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 58048-0005-1 identifies a specific commercial package of 60 ml in 1 bottle, dropper of Lyme And Co-infection Nosode, a human over the counter drug labeled by Bhp Holdings, Inc.. This liquid is formulated for oral use and contains angelica archangelica root; anhydrous citric acid; arnica montana; babesia microti; borrelia burgdorferi; causticum; chlamydia trachomatis; goldenseal; human herpesvirus 5; latrodectus mactans; ledum palustre twig; magnesium phosphate, dibasic trihydrate; manganese; oxalic acid; phytolacca americana root; potassium chloride; rickettsia prowazekii; sus scrofa cartilage; toxicodendron pubescens leaf; yucca filamentosa as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bhp Holdings, Inc. on March 17, 2020.

How is this Bhp Holdings, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 58048000501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
58048-0005-1
11-Digit CMS (5-4-2)
58048-0005-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.